MET and neoplasm: Therefore, the EC90 for cMet phosphorylation inhibition was found to align with the EC50 for tumor growth inhibition, indicating that achieving near-complete suppression of cMet phosphorylation (>90%) is necessary to obtain substantial tumor growth reduction (>50%).